TY - JOUR
T1 - Pharmacogenomics education
T2 - International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools Deans of Education
AU - Gurwitz, D.
AU - Lunshof, J. E.
AU - Dedoussis, G.
AU - Flordellis, C. S.
AU - Fuhr, U.
AU - Kirchheiner, J.
AU - Licinio, J.
AU - Llerena, A.
AU - Manolopoulos, V. G.
AU - Sheffield, L. J.
AU - Siest, G.
AU - Torricelli, F.
AU - Vasiliou, V.
AU - Wong, S.
PY - 2005
Y1 - 2005
N2 - Pharmacogenomics would be instrumental for the realization of personalized medicine in coming decades. Efforts are evident to clarify the potential bioethical, societal, and legal implications of key pharmacogenomics-based technologies projected to be soon introduced into the core practice of medicine. In sharp contrast, a lack of sufficient attention to educational aspects of pharmacogenomics, both for professionals and for society at large, is evident. In order to contribute to this discussion, a 'Pharmacogenomics Education Forum' was held on October 2, 2004 during the 3rd Annual Meeting of the International Society of Pharmacogenomics (ISP) at Santorini, Greece. The participants, members of the ISP Pharmacogenomics Education Forum, after deliberate discussions, proposed a document of 'Background Statement' and 'Recommendations and Call for Action' addressed to Deans of Education at Medical, Pharmaceutical, and Health Schools globally. This document has been considered by the education committee of the International Society of Pharmacogenomics and the result is presented here. We hope that this call would be listened to, and soon followed by beneficial action, ultimately leading to enhanced implementation of personalized medicine into core medical education and practice.
AB - Pharmacogenomics would be instrumental for the realization of personalized medicine in coming decades. Efforts are evident to clarify the potential bioethical, societal, and legal implications of key pharmacogenomics-based technologies projected to be soon introduced into the core practice of medicine. In sharp contrast, a lack of sufficient attention to educational aspects of pharmacogenomics, both for professionals and for society at large, is evident. In order to contribute to this discussion, a 'Pharmacogenomics Education Forum' was held on October 2, 2004 during the 3rd Annual Meeting of the International Society of Pharmacogenomics (ISP) at Santorini, Greece. The participants, members of the ISP Pharmacogenomics Education Forum, after deliberate discussions, proposed a document of 'Background Statement' and 'Recommendations and Call for Action' addressed to Deans of Education at Medical, Pharmaceutical, and Health Schools globally. This document has been considered by the education committee of the International Society of Pharmacogenomics and the result is presented here. We hope that this call would be listened to, and soon followed by beneficial action, ultimately leading to enhanced implementation of personalized medicine into core medical education and practice.
KW - Adverse drug reactions (ADRs)
KW - Continuing medical education
KW - Cytochrome P450 enzymes
KW - Education
KW - International Society of Pharmacogenetics (ISP)
KW - Personalized medicine
KW - Pharmacogenetics
KW - Thiopurine methyltransferase (TPMT)
UR - http://www.scopus.com/inward/record.url?scp=23644449909&partnerID=8YFLogxK
U2 - 10.1038/sj.tpj.6500312
DO - 10.1038/sj.tpj.6500312
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:23644449909
SN - 1470-269X
VL - 5
SP - 221
EP - 225
JO - Pharmacogenomics Journal
JF - Pharmacogenomics Journal
IS - 4
ER -